Cargando…
Novel biomarkers for early targeted and individualized treatment in Juvenile Idiopathic Arthritis
BACKGROUND: The programmed cell death protein-1 (PD-1) and its ligands (PD-L 1 and 2) suppress immune responses, thus promoting self-tolerance. Among the immunomodulatory cells, acting through the PD-1 pathway, are the B-regulatory cells (Bregs). The role of the PD-1 pathway in Juvenile Idiopathic A...
Autores principales: | Koutsonikoli, Artemis, Taparkou, Anna, Pratsidou-Gkertsi, Polyxeni, Sgouropoulou, Vassiliki, Dimitroulas, Theodoros, Trachana, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Mediterranean Journal of Rheumatology (MJR)
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362122/ https://www.ncbi.nlm.nih.gov/pubmed/32676564 http://dx.doi.org/10.31138/mjr.31.2.230 |
Ejemplares similares
-
Τhe genetics of juvenile idiopathic arthritis: Searching for new susceptibility loci
por: Zervou, Maria I., et al.
Publicado: (2017) -
Long-term impact of juvenile idiopathic arthritis in the Greek adults' psychosocial life
por: Dimopoulou, Despoina, et al.
Publicado: (2014) -
A biopsychosocial approach to parents of children with juvenile idiopathic arthritis
por: Georgiadou, Z, et al.
Publicado: (2011) -
Clinical remission off medication in greek adults with juvenile idiopathic arthritis during a 17 year follow-up period
por: Dimopoulou, Despoina, et al.
Publicado: (2014) -
The impact of a 2-year Etanercept administration on growth of patients with juvenile idiopathic arthritis
por: Trachana, M, et al.
Publicado: (2011)